Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTEG.L Regulatory News (TEG)

  • There is currently no data for TEG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD)

14 Dec 2023 10:35

RNS Number : 8408W
Ten Entertainment Group PLC
14 December 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TEN ENTERTAINMENT GROUP PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TEN ENTERTAINMENT GROUP PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

14 DECEMBER 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary £0.01

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

 

NIL

 

(2) Cash-settled derivatives:

 

NIL

 

NIL

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

 

NIL

 

 

TOTAL:

NIL

 

NIL

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by the directors of Ten Entertainment Group PLC

 

Name

No of ordinary shares in Ten Entertainment Group plc

Percentage of total issued share capital

Graham Blackwell

87,645

0.12%

Antony Smith

92,403

0.13%

Adam Bellamy

40,000

0.05%

Julie Sneddon

80,000

0.11%

Christopher Mills(1)

200,000

0.29%

 

(1) Christopher Mills is a Non Executive Director of TEG and he and his family are the shareholders of the entire issued share capital of Harwood Capital Management Limited, which is the sole shareholder of Harwood Capital LLP. 200,000 ordinary shares are held directly by Christopher Mills beneficially in TEG and a further 10,581,000 ordinary shares are held by Harwood Capital LLP (on behalf of its and funds managed or advised by it) in TEG as disclosed per Form 8.3 dated 6 December 2023. 

 

(b) Interests held as options or awards under the share plans of Ten Entertainment Group PLC by the directors of Ten Entertainment Group PLC

 

Name

Maximum number of Shares subject to Outstanding Awards

Number of shares subject to awards vested or expected to vest(2)

Date of grant

Date of Expiry

Exercise Price per Share (£)

Vesting and Exercise Periods

Graham Blackwell

 

 

 

233,083

233,083

30/11/20

30/11/30

£0.01

The vesting of awards is conditional upon the achievement of targets set at the time of grant, measured at the end of a three-year period.

172,862

172,862

14/10/21

14/10/31

£0.01

178,161

124,713

30/3/22

30/3/32

£0.01

164,368

57,529

22/3/23

22/3/33

£0.01

Antony Smith

 

 

 

195,489

195,489

30/11/20

30/11/30

£0.01

144,981

144,981

14/10/21

14/10/31

£0.01

149,425

104,597

30 /3/22

30/3/32

£0.01

138,053

48,318

22 /3/23

22 /3/33

£0.01

 

(2) Pursuant to the rules of the TEG Share Plan, the TEG remuneration committee has determined that the Outstanding Awards will vest, based on the extent to which any relevant performance conditions have been satisfied and the proportion of any performance period that has elapsed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 DECEMBER 2023

Contact name:

ANTONY SMITH

Telephone number:

+44 (0) 203 441 0700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAEALFASDFFA
Date   Source Headline
19th Jun 20207:00 amRNSDirector/PDMR Shareholding
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
18th Jun 20203:31 pmRNSResults of the Annual General Meeting
15th Jun 20204:40 pmRNSSecond Price Monitoring Extn
15th Jun 20204:35 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 20204:40 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSDirector/PDMR Shareholding
22nd May 202012:18 pmRNSVesting of 2017 Directors Performance Share Plan
22nd May 20207:00 amRNSNotice of Annual General Meeting 2020
21st May 20204:41 pmRNSSecond Price Monitoring Extn
21st May 20204:36 pmRNSPrice Monitoring Extension
14th May 20204:36 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSFull-Year Results
28th Apr 20204:13 pmRNSNotice of Full-Year Results
17th Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20203:54 pmRNSDirector/PDMR Shareholding
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 20207:00 amRNSResult of Placing
25th Mar 20204:36 pmRNSPlacing of Ordinary Shares
23rd Mar 20207:00 amRNSSite Closure and Postponement of Results
19th Mar 20204:42 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension
15th Jan 20207:00 amRNSFull-Year Trading Update
2nd Jan 20202:29 pmRNSNotice of Full-Year Trading Update
23rd Dec 20193:33 pmRNSHolding(s) in Company
20th Dec 20195:30 pmRNSDirector/PDMR Shareholding
20th Dec 20191:22 pmRNSHolding(s) in Company
20th Dec 201910:38 amRNSHolding(s) in Company
19th Dec 201911:49 amRNSDirector/PDMR Shareholding
19th Dec 20197:20 amRNSDirector/PDMR Shareholding
18th Dec 20199:56 amRNSDirector/PDMR Shareholding
17th Dec 201910:44 amRNSHolding(s) in Company
17th Dec 201910:39 amRNSHolding(s) in Company
11th Dec 201910:39 amRNSDirector/PDMR Shareholding
10th Dec 20192:49 pmRNSDirector/PDMR Shareholding
21st Nov 201910:55 amRNSHolding(s) in Company
21st Nov 201910:51 amRNSDirector/PDMR Shareholding
14th Nov 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSHalf-Year Results
10th Jul 20197:00 amRNSHalf-Year Trading Update
1st Jul 20199:05 amRNSNotice of Half-Year Trading Update
12th Jun 20194:20 pmRNSHolding(s) in Company
10th Jun 201912:14 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.